What are NTRA's recent SEC filings?
8-K · Guidance RaiseNov 5, 2026
Natera reported Q3 2026 total revenues of $794.0 million, up 34.1% year-over-year, and raised its full-year 2026 revenue guidance by $140 million at the midpoint to $3.005-$3.035 billion. The company also reported a net loss of $59.9 million, or $0.42 per diluted share, and processed approximately 1,093,100 tests in the quarter.
View full filing details →Q3 2026 total revenues: $794.0M, Q3 2025 total revenues: $592.2M, Q3 2026 net loss: $-59900000, Q3 2026 net loss per diluted share: $-0.42, Full-year 2026 revenue guidance low: $3.0B, Full-year 2026 revenue guidance high: $3.0B, Cash, cash equivalents, and restricted cash as of September 30, 2026: $1.1B
10-Q · OtherNov 5, 2026
Natera, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and business developments including the Foresight Diagnostics acquisition.
View full filing details →Has NTRA ever done a stock split?
No stock splits are recorded for NTRA.
What is NTRA's share float?
Public Float
$52.7M
Shares Outstanding
$144.1M
Free Float %
3655.5%
Get Real-Time NTRA Intelligence
SEPT X-Ray combines SEC filings with price targets, support/resistance levels, and smart money tracking — updated every 30 minutes.
Try SEPT X-Ray Free